High-dose N = 64 | Low-Dose N = 60 (59a) | Significanceb, high-dose vs. low-dose group | |
---|---|---|---|
ᅟMSF Baseline Mean ± SD | 2.9 ± 2.7 | 2.0 ± 1.7 | p = 0.030 |
ᅟ95 CI of mean | 2.2 - 3.6 | 1.6 – 2.5 | |
ᅟMSF During phase 1 Mean ± SD | 1.2 ± 1.7 | 1.3 ± 1.8 | p = 0.751 |
ᅟ95 CI of mean | 0.7 - 1.6 | 0.8 - 1.7 | |
ᅟMSF Change to baseline Mean ± SD | −1.7 ± 2.8 | −0.8 ± 2.0 | p = 0.044 |
ᅟ95 CI of mean | −2.4 - -1.1 | −1.3 - -0.3 | |
ᅟSeizure free animals during phase 1 [n] | 24 of 64 | 19 of 60 | p = 0.495 |
Transition to phase 2 | N = 53 of 64 | N = 47 of 60 | |
ᅟMSF During phase 2 Mean ± SD | 1.2 ± 1.3 | 0.9 ± 1.4 | p = 0.269 |
ᅟ95 CI of mean | 0.8 - 1.5 p = 0.688c | 0.5 - 1.4 p =0.369c | |
ᅟSeizure free animals at start of phase 2 [n] | 16 of 53 | 14 of 47 | p = 0.965 |
ᅟSeizure free animals during phase 2 [n] | 17 of 53 p = 0.540c | 22 of 47 p = 0.110c | p = 0.132 |